Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to current ...

Renatus Tactical Acquisition Corp I does not have significant operations. The company intends to effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar ...

Mar. 7, 2026 Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ...

Marshall Hargrave is a stock analyst and writer with 10+ years of experience covering stocks and markets, as well as analyzing and valuing companies. Khadija Khartit is a strategy, investment, and ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Featured here, the Cash Flow Statement for Renatus Tactical Acquisition I Corp, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing ...

As the best-selling vehicle for Volkswagen in North America, the Jetta remains the brand's entry-point. The Jetta slots below the midsize Passat and is also available as a performance-focused model ...

Genesis is Hyundai's luxury arm, and the Santa Fe isn't on the level of a GV80 SUV. Even so, the 2023 Santa Fe is more premium than other SUVs from the Korean automaker. High-end models have upscale ...